Michael S. Cuffe - Jan 31, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and Chief Clinical Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 31, 2024
Transactions value $
-$981,734
Form type
4
Date filed
2/2/2024, 06:38 PM
Previous filing
May 2, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Gift $0 -728 -2.52% $0.00 28.1K Jan 31, 2024 Direct F1
transaction HCA Common Stock Sale -$982K -3.2K -11.38% $306.79 24.9K Jan 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +12.7K $0.00 12.7K Jan 31, 2024 Common Stock 12.7K $304.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.